MAM
Monaco Asset Management Portfolio holdings
AUM
$337M
1-Year Est. Return
32.27%
This Fund
S&P 500
1 Year Est. Return
+32.27%
AUM
$269M
AUM Growth
+$4.59M
(+1.7%)
Holding
112
Top Buys
| 1 | +$14.5M | |
| 2 | +$13.8M | |
| 3 | +$7.68M | |
| 4 |
Maravai LifeSciences
MRVI
|
+$7.09M |
| 5 |
Arcellx
ACLX
|
+$5.66M |
Top Sells
| 1 | +$28.3M | |
| 2 | +$21M | |
| 3 | +$13.1M | |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$11.3M |
| 5 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$9.32M |
Sector Composition
| 1 | Healthcare | 38.55% |
| 2 | Materials | 18.62% |
| 3 | Energy | 16.64% |
| 4 | Consumer Discretionary | 12.41% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Perrigo
PRGO
$1.63B
| $3.9M | 1.45% |
175,000
-31,695
|
|
||
|
SOL
27
DELISTED
Emeren Group
SOL
| $3.79M | 1.41% |
2,005,152
|
|
||
28
Gossamer Bio
GOSS
$91.5M
| $3.63M | 1.35% |
1,379,416
-2,170,584
|
|
||
29
JD.com
JD
$41.8B
| $3.5M | 1.3% |
100,000
-10,000
|
|
||
30
Banco Macro
BMA
$4.96B
| $3.5M | 1.3% |
82,700
+69,700
|
|
||
31
Novavax
NVAX
$1.38B
| $3.47M | 1.29% |
400,000
+170,000
|
|
||
32
Zoom
ZM
$27.1B
| $3.3M | 1.23% |
+40,000
|
|
||
33
QuidelOrtho
QDEL
$810M
| $2.58M | 0.96% |
87,700
+7,700
|
|
||
34
AdvisorShares Pure US Cannabis ETF
MSOS
$1.04B
| $2.54M | 0.95% |
530,000
-595,000
|
|
||
35
uniQure
QURE
$1.11B
| $2.33M | 0.87% |
39,913
-30,087
|
|
||
36
Noble Corp
NE
$7.64B
| $2.26M | 0.84% |
80,000
-145,000
|
|
||
37
Bunge Global
BG
$24.4B
| $2.03M | 0.76% |
25,000
+5,000
|
|
||
|
MREO
38
Mereo BioPharma
MREO
$51.3M
| $1.95M | 0.73% |
945,915
+550,915
|
|
||
39
B2Gold
BTG
$6.5B
| $1.86M | 0.69% |
376,398
-123,602
|
|
||
|
DVS
40
DELISTED
Dolly Varden Silver Corp
DVS
| $1.51M | 0.56% |
300,600
-5,000
|
|
||
41
Inogen
INGN
$195M
| $1.5M | 0.56% |
183,242
+5,648
|
|
||
42
GrowGeneration
GRWG
$78.7M
| $1.39M | 0.52% |
745,946
-269,797
|
|
||
43
Heron Therapeutics
HRTX
$192M
| $1.26M | 0.47% |
1,002,476
-77,524
|
|
||
44
Vanda Pharmaceuticals
VNDA
$404M
| $1.24M | 0.46% |
247,805
-57,195
|
|
||
45
Pliant Therapeutics
PLRX
$79.9M
| $1.22M | 0.45% |
822,693
+120,300
|
|
||
46
Galapagos
GLPG
$1.92B
| $1.16M | 0.43% |
33,536
-2,500
|
|
||
47
Talos Energy
TALO
$2.51B
| $1.05M | 0.39% |
110,000
+25,000
|
|
||
48
Devon Energy
DVN
$29.3B
| $1.05M | 0.39% |
30,000
|
|
||
49
Teva Pharmaceuticals
TEVA
$36.4B
| $1.01M | 0.38% |
50,000
-50,000
|
|
||
50
Weatherford International
WFRD
$7.24B
| $992K | 0.37% |
14,500
-50,500
|
|